Celularity, Inc. (CELU) vs Grace Therapeutics, Inc. (GRCE)
- Celularity, Inc. CELU 1.25 −6.02%
- Grace Therapeutics, Inc. GRCE 1.89 −3.08%
Celularity, Inc. and Grace Therapeutics, Inc. are both Biotechnology companies. Celularity, Inc. and Grace Therapeutics, Inc. are of similar size ($43.2M and $41.0M). Grace Therapeutics, Inc. grew revenue faster over the last twelve months: 1,286.8% against −62.8%. Grace Therapeutics, Inc. has the higher net margin (0.00% vs −375.9%) and the higher return on invested capital (−43.4% vs −695.7%). Across the 17 metrics below, Grace Therapeutics, Inc. leads on 9 and Celularity, Inc. on 8.
Valuation
Profitability
| Metric | CELU | GRCE | Biotechnology median |
|---|---|---|---|
| Gross margin | 5.26% | 0.00% | 65.16% |
| Operating margin | (321.32%) | 0.00% | 0.00% |
| Net margin | (375.89%) | 0.00% | 0.00% |
| Free cash flow margin | (46.46%) | 0.00% | 0.00% |
| Return on equity | 349.83% | (36.19%) | (56.36%) |
| Return on assets | (62.45%) | (33.74%) | (48.04%) |
| Return on invested capital | (695.71%) | (43.36%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack